WANTAI BIOLOGICAL(SH:603392) Sou Hu Cai Jing·2025-07-31 22:54Trading Information Summary - On July 31, 2025, Wante Bio (603392) closed at 58.54 CNY, down 0.31%, with a turnover rate of 0.4% and a trading volume of 50,300 shares, amounting to a total transaction value of 296 million CNY [1] - On the same day, the fund flow for Wante Bio showed a net outflow of 538,100 CNY from institutional investors, accounting for 0.18% of the total transaction value, while retail investors had a net outflow of 1,267,360 CNY, representing 4.28% of the total transaction value [1][3] Company Announcement Summary - Wante Bio announced the redemption of 700 million CNY from a structured deposit product linked to the exchange rate, which was purchased from the Industrial and Commercial Bank of China [1] - The company held meetings on January 15, 2024, and January 14, 2025, to approve the use of idle fundraising for cash management, allowing for investments in safe and liquid principal-protected products, with a maximum investment limit of 2 billion CNY and 1.5 billion CNY for different fundraising sources [1] - As of the announcement date, Wante Bio had invested a total of 2,129.15 million CNY in financial management over the past twelve months, recovering 1,550 million CNY in principal and earning 38.19 million CNY in returns, with an outstanding principal amount of 579.15 million CNY [1]